Evidence map›Paper›PMID 38344568›Full record

ArticleCureus2024

The Effect of Double Carbapenem Regimen in the Management of Carbapenem-Resistant Klebsiella pneumoniae Infections: A Report of Five Cases.

Radhika Soanker, Lakshmi Vemu, Sukanya Vimala, Padmaja Kanne, Venu M Thumma, Gayatri Chavala

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Targeting KPC-ProducingMicroorganisms · 2026
    Article
  3. The Use of CHROMIDAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Radhika SoankerPharmacology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, IND.
Lakshmi VemuMicrobiology, Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, IND.
Sukanya VimalaMicrobiology, Nizam's Institute of Medical Sciences, Hyderabad, IND.
Padmaja KanneMicrobiology, Nizam's Institute of Medical Sciences, Hyderabad, IND.
Venu M ThummaSurgical Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, IND.
Gayatri ChavalaClinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, IND.
Nizam's Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of infections caused by carbapenem-resistant organisms is challenging. Carbapenems in combination with vaborbactam and relebactam are recommended to treat infections caused by extensively drug-resistant organisms including carbapenemase-producing isolates, while ceftazidime-avibactam plus aztreonam, or cefiderocol is recommended for infections caused by New Delhi metallo beta-lactamase (NDM)-producing

Indexed as

difficult to treat pathogensextensively-drug resistantk. pneumoniae producing carbapenemasemetallo beta-lactamasepan-drug resistant

Identifiers

PMID38344568
PMCPMC10854998
OpenAlexW4390704122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.